Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France

作者: Laurence Clerc , Valérie Jooste , Catherine Lejeune , Bernard Schmitt , Patrick Arveux

DOI: 10.1007/S10198-007-0083-0

关键词: Emergency medicinePublic healthTotal costMedicinePopulationIndirect costsAmbulatory careMass screeningFamily medicineHealth economicsHealth care

摘要: Little is known about the economic burden associated with colorectal cancer in France. The aim of this study was to evaluate effects age, stage at diagnosis, health care pattern and level comorbidities on mean cost management cancers, using data from a population-based registry French system. We estimated direct costs medical for 384 cancers diagnosed 2004, three main databases National Health Insurance. defined as sum all expenditures over 12 months following date diagnosis. first-year 24,966€ (SE 1,195€). There no significant difference overall relation sex, Charlson index score, location or pattern. Costs increased significantly extension 17,596€ I 35,059€ IV. Hospitalisation charges represented greatest (55.2%), followed by purchases (24.4%), outpatient (17.8%) transportation (2.5%). These results confirm major indicate that total depend mainly By improving mass screening could contribute decreasing managing cancers.

参考文章(26)
Fabio Levi, Patrick Maisonneuve, Rosa Filiberti, Carlo La Vecchia, Peter Boyle, Cancer incidence and mortality in Europe Sozial-und Praventivmedizin. ,vol. 34, ,(1989) , 10.1007/BF02148558
Le Petit C, Ng E, Berthelot Jm, Maroun J, Flanagan Wm, Dahrouge S, Walker H, Evans Wk, Lifetime costs of colon and rectal cancer management in Canada. Chronic Diseases in Canada. ,vol. 24, pp. 91- 101 ,(2003)
Simon G Thompson, Julie A Barber, How should cost data in pragmatic randomised trials be analysed? BMJ. ,vol. 320, pp. 1197- 1200 ,(2000) , 10.1136/BMJ.320.7243.1197
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
Ruth Etzioni, Scott D Ramsey, Scott D Ramsey, Kristin Berry, Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer The American Journal of Gastroenterology. ,vol. 97, pp. 440- 445 ,(2002) , 10.1016/S0002-9270(01)04045-X
S. Manfredi, A. M. Bouvier, C. Lepage, C. Hatem, V. Dancourt, J. Faivre, Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population British Journal of Surgery. ,vol. 93, pp. 1115- 1122 ,(2006) , 10.1002/BJS.5349
F. Delco, R. Egger, P. Bauerfeind, C. Beglinger, Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland. Alimentary Pharmacology & Therapeutics. ,vol. 21, pp. 615- 622 ,(2005) , 10.1111/J.1365-2036.2005.02362.X
P. Ross, J. Heron, D. Cunningham, Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens. European Journal of Cancer. ,vol. 32, ,(1996) , 10.1016/S0959-8049(96)00334-6
Catherine Lejeune, Christine Binquet, Franck Bonnetain, Amel Mahboubi, Michal Abrahamowicz, Thierry Moreau, Maria Raikou, Laurent Bedenne, Catherine Quantin, Claire Bonithon-Kopp, Estimating the cost related to surveillance of colorectal cancer in a French population European Journal of Health Economics. ,vol. 10, pp. 409- 419 ,(2009) , 10.1007/S10198-009-0144-7